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Introduction
Inherited retinal diseases are heterogeneous in both their
pathology and genetic origin. These diseases are characterized
by the premature and progressive loss of rod and cone
photoreceptor cells. A large number of loci have been
implicated in causing retinal disorders (Rivolta et al., 2002;
Saleem and Walter, 2002). Owing to the heterogeneous nature
of retinal diseases, there have been many molecular
mechanisms implicated. The disruption of genes that encode
proteins involved in the phototransduction cascade,
metabolism of the retinal chromophore of rhodopsin, and the
structural support of photoreceptors have been shown to be
responsible for the observed pathology.
The Drosophila visual system has proved to be an excellent
model system for the study of retinal degeneration (Hardie
and Raghu, 2001; Montell, 1999; Zuker, 1996). The
phototransduction cascade in Drosophila is initiated by a
photon of light activating the major light-sensitive receptor,
rhodopsin (Rh1). Once activated, Rh1 catalyzes the exchange
of GDP for GTP on the G subunit (Gq) of the heterotrimeric
G protein to which it is coupled. The Gq subunit then
dissociates from the inhibitory  subunits and is able to
activate retinal-specific phospholipase C, eventually leading to
the opening of the cation-specific channels Trp and Trpl.
The influx of cations through Trp and Trpl leads to the
depolarization of the photoreceptor cell and neurotransmitter
release.
The regulation of the visual transduction cascade is crucial
for temporal resolution as well as adaptation to varying
intensities of light. One key aspect of regulation is the
inactivation of rhodopsin. In vertebrates, this inactivation is
achieved by two proteins, rhodopsin kinase and arrestin
(Bennett and Sitaramayya, 1988; Kühn and Wilden, 1987).
Rhodopsin kinase phosphorylates the C-terminal tail of
rhodopsin, which partially decouples it from the pathway.
Arrestin is then able to bind the phosphorylated form of
rhodopsin and completely inactivate it, presumably by
competing for a common binding site with G. In addition to
their role in inactivating receptors, arrestins have also
been implicated in receptor internalization. This is best
characterized by the non-visual system arrestins (-arrestins),
which trigger the internalization of these receptors by
recruiting clathrin to the plasma membrane via a ‘clathrin box’
in the extreme C terminus (Ferguson et al., 1996; Goodman, Jr
et al., 1996). Recently, an interaction between -arrestin and
the AP-2 adaptor complex has also been demonstrated to be
critical for receptor endocytosis (Laporte et al., 2000). Visual
arrestins have traditionally been discounted as serving the role
of recruiting rhodopsin to clathrin-coated pits largely because
they do not contain a clathrin-binding domain. However, recent
work in Drosophila has implicated visual arrestins in
rhodopsin endocytosis. The minor visual arrestin (Arr1) has
been demonstrated to be essential for light-induced Rh1
internalization (Satoh and Ready, 2005), and the more
abundant Arr2 has been shown to be involved in rhodopsin
endocytosis under certain pathological situations (Alloway et
al., 2000; Kiselev et al., 2000; Lee et al., 2003). Moreover, it
has been demonstrated that Arr2 can interact with clathrin in
vitro (Kiselev et al., 2000).
Previously, we and others have identified a novel retinal
Previously, we have identified a class of retinal
degeneration mutants in Drosophila in which the normally
transient interaction between arrestin2 (Arr2) and
rhodopsin is stabilized and the complexes are rapidly
internalized into the cell body by receptor-mediated
endocytosis. The accumulation of protein complexes in the
cytoplasm eventually results in photoreceptor cell death.
We now show that the endocytic adapter protein AP-2 is
essential for rhodopsin endocytosis through an Arr2–AP-
2 interaction, and mutations in Arr2 that disrupt its
interaction with the  subunit of AP-2 prevent endocytosis-
induced retinal degeneration. We further demonstrate that
if the interaction between Arr2 and AP-2 is blocked, this
also results in retinal degeneration in an otherwise wild-
type background. This indicates that the Arr2–AP-2
interaction is necessary for the pathology observed in a
number of Drosophila visual system mutants, and suggests
that regular rhodopsin turnover in wild-type photoreceptor
cells by Arr2-mediated endocytosis is essential for
photoreceptor cell maintenance.
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degeneration pathway in Drosophila photoreceptors that is
characterized by persistent complexes between arrestin and
rhodopsin that form at the rhabdomeric membrane (Alloway et
al., 2000; Kiselev et al., 2000). These stable complexes are
toxic because of the extensive endocytosis of the receptor into
the photoreceptor cell body (Alloway et al., 2000; Orem and
Dolph, 2002b). Although the photoreceptor cells undergo what
appears to be programmed cell death, it has been demonstrated
that death does not occur by classic developmental apoptosis
(Hsu et al., 2004) and may therefore involve an alternative cell
death pathway. Here we report that an AP-2 interaction motif
found in the C terminus of Arr2 is essential for endocytosis-
mediated photoreceptor cell death. Furthermore, we show
that AP-2-mediated internalization of Rh1 in wild-type
photoreceptors is essential for the maintenance of normal
retinal morphology.
Results
The AP-2 adaptor complex is required for the norpA-
mediated endocytosis of rhodopsin-arrestin complexes
We have previously shown that mutations in the eye-specific
phospholipase C gene (norpA) cause persistent complexes of
rhodopsin and Arr2 (Alloway et al., 2000), and that these
complexes are rapidly removed from the rhabdomere resulting
in approximately 80% of the Rh1 being internalized into the
cell body (Orem and Dolph, 2002a). Arrestin disassociates
from Rh1 once in the cytoplasm and the rhodopsin accumulates
as cytoplasmic aggregates. This massive endocytosis
eventually results in photoreceptor apoptosis (Orem and
Dolph, 2002b). Recently, a physical interaction between AP-2
and -arrestin has been demonstrated to be important in the
endocytosis of the -adrenergic receptor (Laporte et al., 2000).
To study the possibility that Arr2 mediates the endocytosis of
Journal of Cell Science 119 (15)
rhodopsin-arrestin complexes through the AP-2 adaptor, we
analyzed flies containing a mutation in the -adaptin gene.
This mutation disrupts the  subunit of the heterotetrameric
AP-2 adaptor complex, thus reducing AP-2 function (Forjanic
et al., 1997; Gonzalez-Gaitan and Jackle, 1997). The P element
insertion in the -adaptin gene results in embryonic lethality,
and therefore, all analysis was performed in somatic mosaic
clones in the adult eye. In wild-type flies, after 24 hours of light
treatment the localization of Rh1 and Arr2 is largely
rhabdomeric (Fig. 1A-C). In norpA flies, persistent complex
formation promotes the internalization of Rh1 and Arr2
resulting in at least 80% of the rhodopsin and most of the
arrestin being removed from the rhabdomere (Fig. 1D-F). This
results in an apparent decrease in Rh1 levels that may be due
to the aggregation of rhodopsin in the cytoplasm or the
degradation of Rh1 in the proteosome or lysosome. In contrast,
the norpA -adaptin double mutant displays a wild-type
phenotype, with the majority of the rhodopsin and arrestin
remaining in the rhabdomere (Fig. 1G-I). Thus the AP-2
adaptor complex plays a critical role in the norpA-mediated
endocytosis of Arr2-rhodopsin complexes.
To investigate the role of the AP-2 adaptor on norpA-
mediated retinal degeneration we examined the retinal
morphology of light-treated flies. Wild-type retinas have a
highly organized structure consisting of rows of ommatidia,
with each ommatidium containing seven photoreceptor cells in
any one plane of section. The photoreceptor cells are
distinguished by the rhabdomeres, which are the dark staining
areas that project into the intraommatidial space (Fig. 2A). This
is in sharp contrast to norpA mutants, which undergo massive
retinal degeneration (Fig. 2B). These mutants exhibit the loss
of ommatidial organization, and most noticeably the shrinking
or disappearance of most of the rhabdomeres. The -adaptin
mutant retinas show some signs of retinal
degeneration with a few large holes in the
sections (Fig. 2C), but the degeneration is
much less severe than in norpA flies.
Previously it has been shown that dynamin
loss-of-function alleles exhibit significant
degeneration (Acharya et al., 2003; Alloway
et al., 2000). However, the -adaptin06694
allele is not a null (Gonzalez-Gaitan and
Jackle, 1997), and therefore, we would not
anticipate the same degree of retinal
degeneration as would be observed if
Fig. 1. The AP-2 adaptor complex is necessary
for the norpA-induced endocytosis of stable
rhodopsin-arrestin complexes. All panels show
cross sections (0.75 m) from a frozen
Drosophila retina stained with both arrestin and
rhodopsin antibodies followed by fluorescein-
and rhodamine-labeled secondary antibodies
respectively. (A-C) Wild-type, (D-F) norpA and
(G-I) norpA;-adaptin. The flies were dark-
reared and then treated with constant room light
for 24 hours prior to fixation. Dissected eyes were
fixed and sectioned as described in Materials and
Methods. A, D and G were stained with arrestin-
specific antibodies, B, E and H were stained with
rhodopsin-specific antibodies, C, F and I are
merged images.
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3143Visual arrestin and AP-2 interaction
endocytosis were completely blocked. Interestingly, in
norpA -adaptin double mutants, the norpA-mediated
retinal degeneration is rescued and the photoreceptors
exhibit wild-type morphology (Fig. 2D). Therefore,
norpA-mediated retinal degeneration is rescued by loss-
of-function alleles of -adaptin. These data
demonstrate that the AP-2 adaptor complex is essential
for the endocytosis of Arr2-rhodopsin complexes, and
is required for the retinal degeneration observed in
norpA mutants.
Single point mutations in the AP-2 binding domain
of arrestin do not disrupt its ability to bind and
regulate rhodopsin
Since it is clear that the AP-2 adaptor complex is
necessary for norpA-mediated retinal degeneration, we
were interested in investigating an interaction between
Arr2 and AP-2. It has long been known that, unlike the
-arrestins, visual arrestins do not contain a clathrin-
interaction domain. However, upon closer examination
of the amino acid alignments, it was clear that both the
-arrestins and the visual arrestins contain a consensus
sequence for interaction with AP-2 (Fig. 3A). This
suggests that visual arrestin and Drosophila Arr2 may
serve to recruit arrestin-rhodopsin complexes to
clathrin-coated pits, through an AP-2 interaction. To
investigate the possibility that arrestin interacts with
AP-2, we constructed two point mutations in the Arr2 C
terminus, arr2K391A and arr2R393A and introduced these
mutations into an arr2null background. These two basic
residues have previously been shown to be essential for
AP-2–-arrestin interaction (Laporte et al., 2000). The
construction of these transgenic flies enabled us to directly test
the interaction between Arr2 and AP-2. The ‘ear’ domain from
the -subunit was expressed in vitro fused in frame with the
maltose-binding protein. Arr2 from wild-type flies bound to the
-adaptin fusion protein whereas lysates from arr2K391A and
arr2R393A failed to show any -adaptin binding (Fig. 3B). This
demonstrates that Drosophila Arr2, either directly or indirectly,
binds to the -subunit of AP-2, and, moreover, the single point
mutations completely eliminate the interaction.
Prior to an examination of the role of these amino acids in
endocytosis, it was imperative to demonstrate that these mutant
proteins are able to regulate rhodopsin in a manner similar to
wild-type arrestins. For example, these mutations could disrupt
the ability of arrestin to interact with rhodopsin, or it is possible
that the variant arrestins will constitutively bind rhodopsin. In
order to investigate the role of these mutations on Arr2
function, they were analyzed by biochemical, ultrastructural
and electrophysiological methodologies.
To examine the interaction between the mutant arrestins and
rhodopsin, we took advantage of a biochemical assay that
measures the binding of the two proteins in response to light
(Alloway and Dolph, 1999). This assay relies on the fact that
the major Drosophila opsin, Rh1, can be photoconverted
between the inactive and active forms by different wavelengths
of light. When Rh1 is converted to the M form by a photon of
blue (480 nm) light, the regulatory protein arrestin binds
rhodopsin and, therefore, is localized to the membrane fraction.
Alternatively, when the M form is converted to the inactive R
form by absorbing a photon of orange (580 nm) light, Arr2 is
released from rhodopsin and subsequently is found in the
soluble fraction. In wild-type flies, all of the Arr2 binds to Rh1
upon blue light stimulation and ~80% is released after orange
light treatment (Fig. 3C). Similarly, when either arr2K391A or
arr2R393A are exposed to blue light virtually all of the Arr2 is
found in the pellet fraction, demonstrating that the amino acid
substitutions have not disrupted the ability of arrestin to bind
rhodopsin. Moreover, both mutant arrestin proteins are able to
release from rhodopsin after orange light stimulus (arr2K391A
~80% release and arrR393A ~50% release). These data
demonstrate that the mutations in the AP-2 binding domain do
not significantly compromise the ability of Arr2 to bind and
release from rhodopsin.
Arrestin function can also be analyzed
electrophysiologically with an electroretinogram (ERG). An
ERG measures the sum of the light-induced electrical activity
of the photoreceptor cells and their downstream neurons. The
electroretinogram of wild-type flies shows a stereotypical trace
where the photoreceptors rapidly depolarize in response to
light, and rapidly repolarize once the light stimulus has
terminated (Fig. 3E). The rate-limiting step in the termination
of the ERG is determined by the binding of Arr2 to rhodopsin
and, therefore, provides a good measure of arrestin function
(Ranganathan and Stevens, 1995). The arr2null flies elicit an
ERG that is significantly different from wild-type. When
flashed with blue activating light arr2null mutant photoreceptor
cells rapidly depolarize and remain depolarized during the light
stimulus just as in wild type, but once the light stimulus is
terminated, the photoreceptor cells repolarize very slowly,
taking about four times longer to terminate the response. This
is because the activated rhodopsin in arr2null flies remains
coupled to the signal transduction pathway until it is decoupled
by the much less abundant arrestin, Arr1 (Dolph et al., 1993).
The arr2K391A and the arr2R393A flies both display a largely
Fig. 2. The AP-2 adaptor complex is necessary for norpA-mediated retinal
degeneration. All panels show cross sections (0.5 m) of retinas from (A)
wild-type, (B) norpA, (C) -adaptin and (D) norpA;-adaptin flies. The flies
were dark-reared and then exposed to 5 days of constant room light prior to
fixation. Tissue was fixed and embedded as described in Materials and
Methods.
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wild-type electroretinogram, which indicates that the variant
arrestins are able to bind and inactivate rhodopsin. The
arr2K391A mutant has a trace that is almost identical to that of
wild type. The arr2R393A mutant exhibits repolarization kinetics
that are much faster than arr2null alleles, but the return to
baseline is slower than tat of wild type. However, it is clear that
both mutants are able to bind and inactivate photoactivated
rhodopsin.
A third method to measure the efficacy of the arrestin
variants is to examine retinal morphology after exposure to 5
days of constant light. The wild-type retina retains its highly
organized structure after 5 days of constant light and shows
very little sign of degeneration (Fig. 4A). However, the retina
from arr2null flies shows severe degeneration due to the defect
in rhodopsin inactivation. Large intracellular holes have
developed and the ommatidial organization is completely lost
(Fig. 4B). This clearly contrasts with both the arr2K391A and
the arr2R393A mutants. These arr2 alleles show some
degeneration, but it is significantly decreased compared to that
of the arr2null allele. (Fig. 4C,D, respectively). Taken together
these data indicate that the mutations in the C-terminal AP-2-
binding domain of Arr2 do not significantly impair the ability
of Arr2 to regulate rhodopsin.
The AP-2 binding domain of arrestin is necessary for the
endocytosis of arrestin-rhodopsin complexes in a norpA
background
Having established that the Arr2 variants serve to regulate
rhodopsin in a manner similar to that of wild-type Arr2, we
investigated the role of the AP-2 binding domain in norpA-
mediated retinal degeneration. As previously described, when
norpA mutants are exposed to 24 hours of constant room
light, at least 80% of the rhodopsin is removed from the
rhabdomere by endocytosis. Additionally, the majority of
Arr2 is also found in the cytoplasm (Fig. 5A). This is in sharp
contrast to the almost wholly rhabdomeric localization of
Journal of Cell Science 119 (15)
Fig. 3. Point mutations in the AP-2 binding domain of Arr2 do not inhibit the binding
of arrestin to rhodopsin or the ability of the mutant arrestins to regulate the
phototransduction cascade. (A) An alignment of  and visual arrestins. The ‘clathrin
box’ found in arr1 and 2 are in bold and italicized. The AP-2 binding domain is in
bold and underlined. The two residues that were mutated for this study are marked
with an asterisk. (B) Head lysates from wild-type, arr2K391A and arr2R393A flies were
generated and incubated with a maltose binding protein–AP-2 Ear domain fusion
protein. Lanes 1-3 show represent head equivalents from the lysate. Lanes 4-6
represent Arr2 protein bound to the AP-2 Ear domain. wt, wild-type; K, arr2K391A;
R, arr2R393A. Overexposure of the blot labeled ‘bound’ failed to show any significant
binding of the K or R point mutants (data not shown) (C) Western blot of fractionated
fly head lysates. Dark-reared flies were treated with either 2 seconds of blue light or 2
seconds of blue light followed by 4 seconds of orange light. wt, wild-type; K,
arr2K391A; R, arr2R393A. Pellet (P) and supernatant (S) fractions were subjected to
SDS-PAGE and western blot analysis. (D) Quantification of the percentage of arrestin
bound to rhodopsin-containing membranes. The data shown are the averages of five
independent experiments. For the blue light treatment the following percentages of
arrestin were bound, wild type 89±9%, arr2K391A 95±5% and arr2R393A 99% ±1%. For
the blue/orange light treatment the following percentages of arrestin were bound,
wild-type 27±10%, arr2K391A 25±19% and arr2R393A 52±20%. Data are means ± s.d.
(E) Electroretinogram analysis of wild-type, arr25, arr2K391A and arr2R393A dark
reared newly eclosed flies. The flies were treated with 1 second of 480 nm (blue) light
and the total electrical response of the eye was measured.
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3145Visual arrestin and AP-2 interaction
both rhodopsin and Arr2 seen in wild-type flies treated with
24 hours of room light (Fig. 1A). Interestingly, both the
arr2K391A and the arr2R393A mutations block the norpA-
induced endocytosis of rhodopsin-arrestin complexes (Fig.
5F,I). Interestingly there are some cytoplasmic puncta
immunoreactive for both arrestin and rhodopsin in the
arr2K391A and the arr2R393A background. This may represent
leaky endocytosis or internalization of Arr2 and Rh1 by an
alternative mechanism. Moreover, another interesting
phenomenon exhibited by the arr2R393A allele is the lack of
Arr2 staining in the R7 cell. We see this routinely and
presently we are unable to provide an explanation for the
missing Arr2 in this cell type. These data
demonstrate that simply by changing one
amino acid that is crucial for the arrestin–AP-
2 interaction it is possible to block the norpA-
induced endocytosis of rhodopsin-Arr2
complexes.
To examine the role of the Arr2–AP-2
interaction in norpA-mediated degeneration,
we examined the retinal morphology of the
Arr2 point mutants in a norpA background.
After 5 days of light, the wild-type flies exhibit
a highly ordered array of ommatidia with no evident
degeneration (Fig. 6A). This is in marked contrast to norpA
flies, which have much smaller rhabdomeres (Fig. 6B).
Strikingly, both the arr2K391A and the arr2R393A mutations
completely rescue the norpA-mediated retinal degeneration
(Fig. 6C and D, respectively). Taken together these data add to
our knowledge of endocytosis-mediated retinal degeneration.
The apoptotic pathway is initiated by the formation of stable
arrestin-rhodopsin complexes. These complexes are then
recruited to clathrin-coated pits by the interaction of the C
terminus of arrestin with AP-2. The massive internalization of
rhodopsin finally results in apoptosis of the photoreceptor cells.
Fig. 4. Point mutations in the AP-2 binding domain of
arrestin do not cause rapid light-dependent
degeneration. All panels are cross sections (0.5 m) of
Drosophila retinas from (A) wild-type, (B) arr2null, (C)
arr2K391A and (D) arr2R393A flies. Dark reared flies were
treated with 5 days of constant room light then fixed
and sectioned as described in Materials and Methods.
Fig. 5. An intact AP-2 binding domain in arrestin
is necessary for norpA-induced endocytosis of
persistent rhodopsin-arrestin complexes. Cross
sections (0.75 m) from a frozen Drosophila
retina were stained with both arrestin and
rhodopsin antibodies followed by fluorescein and
rhodamine-labeled secondary antibodies,
respectively. (A-C) norpA, (D-F) norpA; arr2K391A
and (G-I) norpA; arr2R393A. The flies were dark-
reared and then treated with constant room light
for 24 hours prior to fixation. Dissected eyes were
fixed and sectioned as described in Materials and
Methods. A, D and G were stained with arrestin-
specific antibodies, B, E and H were stained with
rhodopsin-specific antibodies, C, F, and I are
merged images.
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Arrestin-mediated internalization of rhodopsin is
essential for photoreceptor cell maintenance
These data suggest that Arr2 plays two roles in wild-type
photoreceptors. First, it binds to and uncouples activated
rhodopsin from the phototransduction pathway, and second, it
suggests that Arr2 also promotes the internalization of
rhodopsin through an interaction with AP-2. Therefore, we
reasoned that mutating this highly conserved domain should
disrupt normal photoreceptor physiology. In order
to test this idea further, wild-type, arr2null,
arr2K391A and arr2R393A flies were treated with a 12-
hour light-dark cycle for 30 days. A cross-section
of wild-type photoreceptors after a 30-day
treatment shows little, if any, degeneration with a
highly ordered array of ommatidia (Fig. 7A). In
contrast, the arr2null ommatidia show severe and
almost complete retinal degeneration, with all
except the R7 rhabdomere completely missing (Fig.
7B). Although, the arr2K391A and arr2R393A mutants
exhibited retinal morphology that was largely intact
after 5 days of light treatment (Fig. 4C,D), longer
treatments under physiological light conditions
produce moderate degeneration (Fig. 7C,D). This
degeneration is characterized by large intracellular
holes and darkened cytoplasm. These data suggest
that the internalization of rhodopsin through Arr2-
mediated endocytosis is essential to maintain
photoreceptor integrity. This defines a new retinal
degeneration mechanism in which defective
internalization and degradation of rhodopsin results
in photoreceptor cell degeneration. Since human
visual arrestin also possesses an identical AP-2
interaction motif, it is likely that rod photoreceptors
also have an essential function of internalizing
rhodopsin through arrestin-mediated endocytosis.
Discussion
In this study our results demonstrate that
Drosophila Arr2 plays a role as a mediator of
rhodopsin endocytosis by interacting with the AP-
2 adaptor complex. We have shown that the AP-2
adaptor complex is required for the endocytosis of
rhodopsin during certain pathological conditions
and that the disruption of this complex rescues
norpA-mediated retinal degeneration. In addition,
we have shown that in flies with a single point
mutation in the AP-2 binding domain of Arr2,
norpA-induced endocytosis of stable rhodopsin-
arrestin complexes and the subsequent retinal
pathology is blocked. Furthermore, internalization
of rhodopsin by an Arr2–AP-2 interaction has been
shown to be essential for photoreceptor cell
viability.
In previous work it has been demonstrated that
certain Arr2 variants bind tightly to rhodopsin
(Alloway and Dolph, 1999). This results in the
recruitment of the endocytic machinery and cell
death via excessive rhodopsin endocytosis. In this
study we have also found an Arr2 variant
(arr2R393A) that binds more tightly to rhodopsin
than wild-type Arr2. However, this mutant does not
trigger extensive retinal degeneration. This is further evidence
for the essential role of the Arr2–AP-2 interaction in receptor
internalization. In this Arr2 background complexes are formed
between Arr2 and Rh1, but since Arr2 cannot interact with AP-
2 they are not internalized and no photoreceptor cell death is
induced.
Our data point to an essential role for the endocytosis of
rhodopsin through Arr2 in the maintenance of photoreceptor
Journal of Cell Science 119 (15)
Fig. 6. The interaction between arrestin and AP-2 is required for norpA-
mediated retinal degeneration. All panels show cross sections (0.5 m) of
Drosophila retinas from (A) wild-type, (B) norpA, (C) norpA; arr2K391A and
(D) norpA; arr2R393A. Dark-reared flies were treated with 5 days of constant
room light then fixed and sectioned as described in Materials and Methods.
Fig. 7. Mutations in the AP-2 binding domain of arrestin cause slow retinal
degeneration. All panels show cross sections (0.5 m) of Drosophila retinas
from (A) wild-type, (B) arr25, (C) arr2K391A and (D) arr2R393A flies. Dark-reared
flies were treated for 30 days of 12 hours light/12 hours dark, then fixed and
embedded as described in Materials and Methods.
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cells. Previous work has implicated an essential role for
Drosophila arrestins in endocytosis; however, these studies
used mutations that either blocked all endocytosis in the
photoreceptor cell or utilized loss-of-function mutants that
could have other effects on the photoreceptor. Photoreceptor
cell degeneration can be induced by inhibiting dynamin
function with a dominant negative mutation (Acharya et al.,
2003) or by blocking AP-2 function (this study). However, it
is possible that a global inhibition of endocytosis may halt the
internalization of compounds essential for cell viability.
Therefore, cell death may be unrelated to defects in the
phototransduction cascade or the internalization of rhodopsin.
In addition, retinal degeneration in Arr1 mutants may be due
to the defect in endocytosis but pleiotropic affects associated
with the loss of Arr1 may also contribute to the aberrant retinal
morphology. By using Arr2 variants that are unable to
internalize rhodopsin, we have selectively blocked the
endocytosis of one protein (rhodopsin) while leaving general
endocytosis intact. Therefore, the retinal degeneration
observed in this study (Fig. 7) is due solely to defects in
rhodopsin internalization through its interaction with Arr2.
One interesting question concerns the purpose of the
essential role for rhodopsin-Arr2 endocytosis. One possibility
is that this may be a mechanism to remove damaged rhodopsin
from the cell. If rhodopsin is photochemically damaged in such
a way that it becomes constitutively active, it would be
deleterious to the cell, and would need to be removed.
Presumably constitutively active rhodopsin would form a
stable complex with Arr2 and be targeted for endocytosis
through  the interaction of arrestin with the AP-2 adaptor
complex. This would provide a surveillance mechanism for the
cell, whereby defective rhodopsin molecules are quickly and
efficiently removed. Second, it may be an adaptive mechanism.
In high light conditions the amount of activated rhodopsin may
exceed the ability of arrestin to quickly decouple the
metarhodopsin from the phototransduction pathway. This
would lead to a loss of visual temporal resolution and be
detrimental to cell viability. However, under high light
conditions at any given time a higher percentage of the cellular
arrestin will be bound to rhodopsin and increase the likelihood
that the Arr2 bound to rhodopsin will interact with AP-2 and
drive internalization of rhodopsin. This would serve to lower
the concentration of rhodopsin available to activate the
phototransduction cascade and thereby reduce sensitivity under
conditions of intense illumination.
Materials and Methods
Drosophila stocks
All Drosophila melanogaster stocks were in a white (w) background to eliminate
screening pigments in the eye. The white mutant (w1118) is a spontaneous mutation
that has been extensively characterized (Lindsley and Zimm, 1992). The norpAEE5
mutation was induced by ethyl methanesulfonate (EMS). The arr25 allele has a stop
codon at amino acid 20 and is referred to as arr2null throughout the text (Dolph et
al., 1993) The -adaptin (-adaptin06694) mutant is a P-element insertion in the first
exon (Gonzalez-Gaitan and Jackle, 1997). The stocks used to produce the eye-
specific somatic mosaic clones were modified from previously described stocks
(Newsome et al., 2000).
Arrestin 2 constructs
The AP-2-binding domain mutations in arr2 were constructed using standard PCR
techniques. The nucleic acid substitutions were induced in a genomic arrestin clone.
Therefore the final clones were driven by the endogenous promoter and contained
all genomic introns and exons. The mutant constructs were inserted into modified
version of the Y.E.S. vector (Patton et al., 1992) and injected into yw fly embryos.
The modified version of the Y.E.S. vector was a generous gift from Steven Britt
(University of Colorado Health Sciences Center). The y+ transformants were then
selected and the arr2 mutant constructs were crossed into an arr2null background.
AP-2 interaction assay
The Ear domain of AP-2 was cloned in frame with the maltose binding protein.
Genomic DNA was amplified by the polymerase chain reaction using the following
primers: GGGAATTCAAGGGCAAGGGACTCGAAATACAAG and ACTGAG-
TGACAAGCAGCTCCGATT. The 900 bp fragment was cloned into the pMAL-
c2X vector using EcoRI and SalI sites. The resulting fusion protein was induced
and purified using amylose resin by standard techniques. A head lysate from 20 flies
was incubated with pMAL-EAR fusion protein bound to amylose beads for 30
minutes at 4°C. The beads were washed three times with column buffer and the
samples were boiled for 5 minutes. Western bots were performed using Arr2
polyclonal antisera.
Somatic mosaics
Somatic mosaic clones in the adult eye were made as previously described
(Newsome et al., 2000) except that the FLP recombinase was provided by a
recombinant chromosome containing both the norpA mutation and the eyFLP
transgene. The -adaptin P element mutation was recombined onto a FRT42
chromosome by standard genetic methods. Eye-specific mosaics were made by
crossing norpA eyFLP; FRT42 cl2R11 females with FRT42 -adaptin males. The
presence of the clR211 recessive cell lethal allele results in a large portion of the
eye being homozygous for the -adaptin mutation in both males and females. In
the resulting progeny, the males were used to analyze norpA; -adaptin double
mutants, whereas the females were heterozygous for the norpA mutation and
therefore used to study the effect of the -adaptin mutation in an otherwise wild-
type background.
Histology
Heads from light-treated flies were removed, bisected and placed in ice cold 2%
glutaraldehyde until all samples were dissected. An equal volume of 2% osmium
tetroxide was added to each sample and then incubated at 4°C for 30 minutes on a
rotary shaker. The glutaraldehyde/osmium tetroxide mix was removed and replaced
with 2% osmium tetroxide, and the samples incubated at 4°C for 1 hour. Samples
were dehydrated with increasing concentrations of ice-cold ethanol. Dehydration
was followed by two 10-minute incubations at room temperature with propylene
oxide. Samples were then incubated overnight with rotation in 50% Durcupan
resin/50% propylene oxide (Fluka). The Durcupan propylene oxide mix was
removed and replaced with 100% Durcupan and the incubation continued for an
additional 4 hours. The samples were cured in molds at 80°C overnight, and 0.5
m sections were cut with a Sorvall MT-1 ultra-microtome (Sorvall, a Kendro
company, Ashville, NC). Tissue was observed with a Zeiss Axiophot (Carl Zeiss
MicroImaging) microscope using a 100/NA 1.3 oil immersion objective. Digital
images were collected using an Optronics DEI 750 camera and MetaVue (Universal
Imaging) image capturing software. Images were processed using Adobe Photoshop
for Windows.
Immunological staining of cross sections of Drosophila
photoreceptors
Newly eclosed dark-reared flies were either kept in the dark or exposed to 24 hours
of constant room light. The eyes were removed and fixed with 4% paraformaldehyde
in PBS for 1 hour. Fixed tissue was rinsed once with PBS and then infused with
40% sucrose in PBS overnight at 4°C. The eyes were then frozen and cut into 0.75
m thick sections using a Sorvall MT5000 ultra microtome with a RMC CR2000
cryo attachment (RMC Products, Tucson AZ). Sections were cut with a sample
temperature of –23°C and a knife temperature of –50°C. The sections were treated
with a blocking solution of PBS + 1% BSA (PBS-B) for 15 minutes at room
temperature and then incubated with antibodies against Arr2 and Rh1 at 4°C
overnight. Antibodies were diluted 1:100 in PBS-B. FITC- and TRITC-conjugated
secondary antibodies (Jackson ImmunoResearch, West Grove, PA) were used at
1:100 for 4 hours at room temperature. Stained sections were observed with a Leica
TCS SP confocal laser-scanning microscope (Leica Microsystems, Heidelberg,
Germany) using a 100/NA 1.4 oil immersion objective. Rhodopsin (TRITC) is
displayed as magenta to be red/green color blind compatible. The co-localization
of FITC (green) and TRITC appears white. The anti-Arr2 antibody was a generous
gift from Rama Rangananthan (University of Texas, Southwestern). The Rh1
antibody (4C5) developed by David Blest was obtained from the Developmental
Studies Hybridoma Bank under the auspices of the NICHD and maintained by The
University of Iowa, Department of Biological Sciences, Iowa City, IA. Images were
processed using Adobe Photoshop 7 for Windows.
Biochemistry
Arr2 bind and release assays were performed as previously described (Alloway and
Dolph, 1999). For the binding assay, five heads were dissected and floated in 30 l
of PBS at room temperature. The heads were then dark adapted for 10 minutes
followed by exposure to 2 seconds of blue (480 nm) light. The heads were
homogenized in the dark and centrifuged for 5 minutes at 13,000 g. The supernatant
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
3148
fraction was removed to a fresh tube under very dim red light. Both the pellet and
supernatant fractions were then placed on ice until SDS/PAGE and western blot
analysis was performed. The release assay followed the same procedure except that
the 2 seconds of blue light was followed immediately by 4 seconds of orange (580
nm) light. Blue and orange illumination were produced with a 300-W
xenon/mercury lamp (Oriel, Stamford, CT) and 480 nm or 580 nm band pass filters
(Oriel), respectively. To quantitate the western blots, the blots were scanned using
a UMAX scanner (UMAX Data Systems) and the band density was analyzed using
Lab Works (UVP Bioimaging Systems Inc.).
Electroretinogram analysis
Electroretinograms were performed on newly eclosed dark-reared adult flies
immobilized on a solid support. The glass electrodes were filled with 0.7% NaCl.
The recording electrode was placed onto the eye and the reference electrode was
inserted into the thorax. Electrical signals were amplified through a DAM50
amplifier (World Precision Instruments, Sarasota, FL), digitized with a MacAdios
ADPO (GW Instruments, Somerville, MA), and viewed with SUPERSCOPE
software (GW Instruments). Stimulating light was generated with a 300 W
xenon/mercury lamp (Oriel) and attenuated with neutral density filters. Blue and
orange light was generated by filtering through 480 nm and 580 nm band-pass filters
(Oriel), respectively. All light pulses were 1 second in duration and at 1/100
maximum intensity.
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